ArticleDiabetology international2022
Efficacy of dulaglutide after switching from incretin-related drugs in patients with type 2 diabetes and inadequate glycemic control.
Hiroyuki Ito et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.